About
TEGA Therapeutics develops glycoscience-based therapies including recombinant heparan sulfate production and enzyme replacement therapies for genetic deficiencies related to heparan sulfate degradation.
Explore TEGA Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.